Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcoa Co. stock logo
AA
Alcoa
$36.77
+2.3%
$32.93
$23.07
$38.20
$6.60B2.456.98 million shs5.50 million shs
Apex Resources Inc. stock logo
APX
Apex Resources
C$0.07
-6.7%
C$0.07
C$0.05
C$0.09
C$2.53M0.5615,400 shs5,000 shs
MTT
Western Asset Municipal Defined Opportunity Trust
$21.19
$21.19
$18.47
$21.59
N/AN/A26,370 shs15,402 shs
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
$1.16
-8.7%
$1.00
$0.51
$4.31
$10.20M-0.11485,219 shs923,663 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcoa Co. stock logo
AA
Alcoa
+2.28%-0.27%-1.10%+24.69%+5.00%
Apex Resources Inc. stock logo
APX
Apex Resources
0.00%0.00%0.00%0.00%-22.22%
MTT
Western Asset Municipal Defined Opportunity Trust
0.00%0.00%0.00%0.00%0.00%
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
-8.66%+35.06%+8.41%-20.00%+115,999,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alcoa Co. stock logo
AA
Alcoa
3.036 of 5 stars
2.02.01.70.03.50.81.9
Apex Resources Inc. stock logo
APX
Apex Resources
N/AN/AN/AN/AN/AN/AN/AN/A
MTT
Western Asset Municipal Defined Opportunity Trust
N/AN/AN/AN/AN/AN/AN/AN/A
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcoa Co. stock logo
AA
Alcoa
2.08
Hold$33.54-8.78% Downside
Apex Resources Inc. stock logo
APX
Apex Resources
N/AN/AN/AN/A
MTT
Western Asset Municipal Defined Opportunity Trust
N/AN/AN/AN/A
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/A

Current Analyst Ratings

Latest APX, MTT, PBM, AA, and URU Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Alcoa Co. stock logo
AA
Alcoa
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$28.50 ➝ $36.50
4/19/2024
Alcoa Co. stock logo
AA
Alcoa
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$27.00 ➝ $32.00
4/18/2024
Alcoa Co. stock logo
AA
Alcoa
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$25.00 ➝ $31.00
4/18/2024
Alcoa Co. stock logo
AA
Alcoa
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$45.00 ➝ $48.00
4/18/2024
Alcoa Co. stock logo
AA
Alcoa
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$35.00 ➝ $37.00
3/18/2024
Alcoa Co. stock logo
AA
Alcoa
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$31.00 ➝ $32.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcoa Co. stock logo
AA
Alcoa
$10.55B0.63$1.30 per share28.26$30.82 per share1.19
Apex Resources Inc. stock logo
APX
Apex Resources
N/AN/AC$0.02 per share4.23C$0.07 per shareN/A
MTT
Western Asset Municipal Defined Opportunity Trust
N/AN/AN/AN/AN/AN/A
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcoa Co. stock logo
AA
Alcoa
-$651M-$3.76N/A17.023.69-6.41%-8.51%-3.60%7/17/2024 (Estimated)
Apex Resources Inc. stock logo
APX
Apex Resources
N/A-C$0.02N/AN/AN/A-17.33%-6.94%6/4/2024 (Estimated)
MTT
Western Asset Municipal Defined Opportunity Trust
N/AN/A0.00N/AN/AN/AN/AN/A
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/A0.00N/AN/AN/AN/AN/A

Latest APX, MTT, PBM, AA, and URU Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/17/2024Q1 24
Alcoa Co. stock logo
AA
Alcoa
-$0.62-$0.81-$0.19-$0.21$2.55 billion$2.60 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alcoa Co. stock logo
AA
Alcoa
$0.401.09%N/AN/A N/A
Apex Resources Inc. stock logo
APX
Apex Resources
N/AN/AN/AN/AN/A
MTT
Western Asset Municipal Defined Opportunity Trust
$0.954.48%N/AN/A1 Years
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/AN/A

Latest APX, MTT, PBM, AA, and URU Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/22/2024
Alcoa Co. stock logo
AA
Alcoa
quarterly$0.101.45%3/4/20243/5/20243/21/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcoa Co. stock logo
AA
Alcoa
0.45
1.61
0.93
Apex Resources Inc. stock logo
APX
Apex Resources
N/A
0.25
1.30
MTT
Western Asset Municipal Defined Opportunity Trust
N/AN/AN/A
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alcoa Co. stock logo
AA
Alcoa
13,600179.56 millionN/AOptionable
Apex Resources Inc. stock logo
APX
Apex Resources
N/A36.16 millionN/ANot Optionable
MTT
Western Asset Municipal Defined Opportunity Trust
N/AN/AN/ANot Optionable
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/A8.79 million8.47 millionN/A

APX, MTT, PBM, AA, and URU Headlines

SourceHeadline
Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)
finance.yahoo.com - April 17 at 12:49 PM
Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)
globenewswire.com - April 17 at 8:00 AM
Psyence Groups NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin TrialPsyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
globenewswire.com - April 16 at 11:01 AM
Psyence Biomed Partners with Fluence and iNGENu CRO to Train Research Therapists for Phase IIb Psilocybin TrialPsyence Biomed Partners with Fluence and iNGENu CRO to Train Research Therapists for Phase IIb Psilocybin Trial
tmcnet.com - April 8 at 12:13 PM
Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin TrialPsyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
globenewswire.com - April 8 at 8:00 AM
Psyence Group Inc.: Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical BusinessPsyence Group Inc.: Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
finanznachrichten.de - March 28 at 6:23 PM
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical BusinessPsyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
globenewswire.com - March 26 at 11:06 AM
Psyence Biomedical Ltd PBMPsyence Biomedical Ltd PBM
morningstar.com - March 24 at 7:23 PM
PBM Psyence Biomedical Ltd.PBM Psyence Biomedical Ltd.
seekingalpha.com - March 22 at 8:02 PM
Psyence Biomedical Ltd (PBM)Psyence Biomedical Ltd (PBM)
uk.investing.com - March 21 at 4:24 PM
Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic PsilocybinPsyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
stockhouse.com - March 18 at 7:19 PM
Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic PsilocybinPsyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
globenewswire.com - March 18 at 4:05 PM
Psyence Biomedical faces Nasdaq delisting over market valuePsyence Biomedical faces Nasdaq delisting over market value
uk.investing.com - March 17 at 3:36 PM
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held SharesPsyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
globenewswire.com - March 15 at 4:30 PM
Psyence Groups NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb StudyPsyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
globenewswire.com - March 12 at 11:15 AM
Psyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future MilestonesPsyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future Milestones
globenewswire.com - March 12 at 7:00 AM
Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In AustraliaPsyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
benzinga.com - March 11 at 7:54 PM
Why Is Psyence Biomedical (PBM) Stock Up 90% Today?Why Is Psyence Biomedical (PBM) Stock Up 90% Today?
investorplace.com - March 8 at 6:17 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Alcoa logo

Alcoa

NYSE:AA
Alcoa Corporation, together with its subsidiaries, produces and sells bauxite, alumina, and aluminum products in the United States, Spain, Australia, Iceland, Norway, Brazil, Canada, and internationally. The company operates through two segments, Alumina and Aluminum. It engages in bauxite mining operations; and processes bauxite into alumina and sells it to customers who process it into industrial chemical products, as well as aluminum smelting and casting businesses. The company offers primary aluminum in the form of alloy ingot or value-add ingot to customers that produce products for the transportation, building and construction, packaging, wire, and other industrial markets; and flat-rolled aluminum in the form of sheet, which is sold primarily to customers that produce beverage and food cans. In addition, it owns hydro power plants that generates and sells electricity in the wholesale market to traders, large industrial consumers, distribution companies, and other generation companies. The company was formerly known as Alcoa Upstream Corporation and changed its name to Alcoa Corporation in October 2016. The company was founded in 1886 and is headquartered in Pittsburgh, Pennsylvania.
Apex Resources logo

Apex Resources

CVE:APX
Apex Resources Inc., an exploration stage company, engages in the exploration and evaluation of mineral properties in Canada. The company primarily explores for gold, copper, lead, zinc, molybdenum, and tungsten deposits. It holds a 100% interest in the Jersey Emerald Tungsten-Lead-Zinc property consisting of 28 crown granted mineral claims, four 2-post claims, and 80 mineral units located in southeastern British Columbia; and the Ore Hill property covering an area of 2,000 hectares located in southern British Columbia. The company was formerly known as Sultan Minerals Inc. and changed its name to Apex Resources Inc. in July 2016. Apex Resources Inc. was incorporated in 1989 and is based in Vancouver, Canada.

Western Asset Municipal Defined Opportunity Trust

NYSE:MTT
Western Asset Municipal Defined Opportunity Trust Inc. is a close-ended fixed income mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. The fund is co-managed by Western Asset Management Company. It invests in fixed income markets of the United States. The fund makes its investments in the securities of companies operating across diversified sectors. It primarily invests its assets in a portfolio of municipal securities. The fund uses value oriented strategy to make its investments. It employs a fundamental analysis with a bottom-up stock picking approach to create its portfolio. The fund conducts in-house research to make its investments. Western Asset Municipal Defined Opportunity Trust Inc. was formed on January 15, 2009 and is domiciled in the United States.
Psyence Biomedical logo

Psyence Biomedical

NASDAQ:PBM
Newcourt Acquisition Corp is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. Newcourt Acquisition Corp is based in Oakland, California.